New Ipilimumab and Nivolumab Clinical Trial For Mesothelioma
Researchers at the University of Chicago Medicine Comprehensive Cancer Center announced a phase II clinical trial. Researchers plan to study the combination of ipilimumab and …
Category: Mesothelioma Clinical Trial